Making a Difference…

WHO WE ARE & WHAT WE DO

Headquartered in Pittsburgh, the Community Liver Alliance has grown to have a national presence while still holding true to a mission to invest in local communities and give voice to patients and providers. The CLA is dedicated to supporting the community through liver disease awareness, prevention, education, advocacy and research.

Supported by a network of patients, caregivers, health care professionals and community leaders, CLA develops and runs educational workshops, coordinates support groups, facilities linkage to medical care and provides education to health care professionals, patients and caregivers.

CLA collaborates with community leaders, interest groups and policy makers on issues related to liver disease health.

CLA's goal is continued growth aligned with mission and strategic plans. With the support of key funding partners, CLA continues to build capacity to address autoimmune liver diseases, the elimination of viral hepatitis and the other rising liver-related epidemics like Fatty Liver/NASH and Hepatocellular Carcinoma.

CLA gives back to local communities through our Liver Hero funds that support Patients, Research and Pediatric Initiatives.

CLA is involved in advancing policy related to healthcare issues at both the state and federal level, regularly providing expertise and amplifying patient and provider voices to help advocates communicate to legislators about important health care issues such as non-medical switching, out of pocket costs for prescription drugs, co-pay accumulator issues, as well as other barriers to health care access, and seek state-level and federal policy remedies.

CLA is YOUR community partner and is dedicated to working with you providing support to the liver community. CLA lives the mission and is committed to providing excellent outcomes for all endeavors, achieved through solid relationships with strategic partners, volunteer leaders and by selecting highly experienced and dedicated staff members to meet the needs of the liver communities across the nation.

CLA is dedicated to supporting harm reduction as a practice and a theory. Meeting people where they are, using proven practical public health strategies to help remove barriers, increasing educational opportunities, expanding health access and treating people with love, respect and dignity has and will continue to help eliminate health disparities including all forms of liver disease.

STAFF

Suzanna Masartis

Suzanna Masartis
Chief Executive Officer

Murock

Johanna Murock
Director of Operations

Harlans

Jill Harlan
Program Director

Kelli Komondor
Campaign Manager

Alison Kost

Alison Kost
Program Director

Ariel Mookherji
Development Director  

Clayton Ruley 
Director of Diversity and Inclusion 

DIVERSITY & INCLUSION

The Community Liver Alliance strives to create an environment where Diversity, Equity and Inclusion flows throughout all we do. This commitment is vital because health disparity populations constitute a large proportion of patients with liver disease. During the pandemic these disparities became more apparent. As we plan our future – our responsibility to integrate DE&I in all we do is at the forefront of our strategic initiatives.  

Further, the Community Liver Alliance is dedicated to perpetually looking inside our organization to remain inclusive, diverse, relevant and responsive to the wider liver community.  To that end, we continue to create strong partnerships with organizations and individuals who enable us to meet our goals, we invest in staff and volunteer leaders to represent the people we seek to support and endeavor to understand how to best center those voices for positive change. 

We specifically mean to act on this in the following ways. 

  • Increasing diversity in our workforce 
  • Engaging in partnerships that parallel our values   
  • Ensuring there is equitable & easier access to tools and resources for all populations, especially those typically marginalized 
  • Developing an environment where every staff and partner feels like they have a true opportunity to have a place at the policymaking table 

We are engaging the Definitions of Diversity, Equity and Inclusion to drive our commitment and programs: 

  • Diversity includes the various perspectives, experiences, skills, strengths, cultures, personal uniqueness, and backgrounds represented in the CLA and its connected communities. 
  • Equity refers to not just equality but understanding that people need to brought to the same level through increased access and opportunity.  We reject people being disadvantaged because of their social determined circumstance(s) or because of their group(s) identity. 
  • Inclusion means accepting, valuing and acknowledging people’s needs, talents, values and voices of each person to grow a culture where people feel like they are valued, heard, respected and included in CLA’s mission and have real leadership opportunities. 

DE&I Opportunities 

We are creating opportunities to help build bridges to healthcare and access to services and resources. Our aim is to affect health and racial equity among the most vulnerable individuals. Evidence suggests that these populations are disproportionately affected by several common hepatic disorders, including viral hepatitis, nonalcoholic fatty liver disease, hepatocellular carcinoma, and in particular, access to liver transplantation.  

Many of our programs will include engagement and outreach to diverse and high-risk communities.  

  • To impact on health equity and racial justice, we have developed an awareness campaign to bring attention to the issues facing vulnerable populations.  
  • To generate understanding within, and equally importantly, outside of the liver community.   
  • To create opportunities to find meaningful and actionable solutions. 

NATIONAL BOARD OF DIRECTORS

Kelly Martin

Kelly Martin, CRNP
Chair
Independent Nurse Practitioner
MedExpress

Wempler

Adele Wampler
Vice President
Field Examiner
Department of Veteran’s Affairs

Skertich

Jennifer Skertich
Education Chair
Security Analyst
FedEx

Wasko

Mark Wasko
Secretary
Transplant Account Manager
CareDx

Tony Ciotti
Treasurer
Managing Director/Head of Finance
Grant Thornton LLP

Chopra

Kapil Chopra, MD
Transplant Hepatologist and Gastroenterologist
UPMC Center for Liver Diseases

DeGregorio

Nick DeGregorio, MD
Senior Medical Director
UPMC Health Plan

Geller

David Geller, MD
Director
UPMC Liver Cancer Center

Mastroianni

Bruno Mastroianni
Chief Information and Supply Chain Officer
Center for Organ Recovery and Education

Mazariegos

George Mazariegos, MD
Chief, Pediatric Transplantation
Children’s Hospital of Pittsburgh

Aaron Martin
Investigative Reporter
WPXI-TV

Stainbrook

Tuesdae Stainbrook, DO, MPH
Principal Owner
TruCare Internal Medicine & Infectious Diseases

Williams

Renee Williams, Esquire
Executive Director
National Center for Victims of Crime

Acevedo

Stacy Acevedo, RN, BSN, MSN
Certified Clinical Transplant Coordinator
UPMC Starzl Transplant Services

Starzl

Thomas E. Starzl, MD, PhD
Posthumous Member

MIDWEST REGIONAL BOARD OF DIRECTORS

Kelly Martin
Wempler
Kaleida
Wasko
Acevedo

Kelly Martin, CRNP
Chair
Independent Nurse Practitioner
MedExpress

Adele Wampler
Vice President
Field Examiner
Department of Veteran’s Affairs

Sandeepa (Sandy) Kaleida
Treasurer
Founder & CEO
Sigma Resources, LLC

Aaron Martin
Education Chair
Investigative Reporter
WPXI-TV

Mark Wasko
Secretary
Transplant Account Manager
CareDx

Stacy Acevedo, RN, BSN, MSN
Certified Clinical Transplant Coordinator
UPMC Starzl Transplant Services